Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Claridge


V.TLT

If with TLD-1433, next Ph. 1b = Cervical or Head&Neck

In fact, cervical and head & neck cancer indications have been identified...

December 3, 2019

V.TLT

RE:PH1b

Jojomarch ... If Rutherrin requires shelf certification, than this one would...

December 3, 2019

V.TLT

RE:RE:RE:RE:from the AGM

Fair to assume that Rutherrin will most probably require a shelf storage...

December 3, 2019

V.TLT

RE:RE:RE:from the AGM

But when reading this: Under long term and accelerated stability storage...

December 3, 2019

V.TLT

RE:RE:from the AGM

EnriqueSuave ... That's my take.  Everything points to th next...

December 3, 2019

V.TLT

RE:RE:RE:RE:From the MD&A - Theralase Research Agreements

Sounds specfic for the GBM indication, when looking for the dates of that...

December 3, 2019

V.TLT

RE:RE:RE:From the MD&A - Theralase Research Agreements

Could also be for the next cancer indication ... Like GBM ... TLD-1433...

December 2, 2019

V.TLT

RE:RE:RE:RE:RE:- 3

Investclub ...  Great post.   Every single SH board has its...

December 2, 2019

V.TLT

RE:RE:From the MD&A - Theralase Research Agreements

Eoganacht ... Great digging.   Here's more perspectives on that...

December 2, 2019

V.TLT

FDA’s accelerated approval programme under scrutiny

Interesting article ... though a bit old now. 23 August 2017...

December 2, 2019

V.TLT

Juno's Ph. 2 Clinical HOLD removed 2 weeks after 2 deaths

Juno CAR-T study put on hold, again, after cerebral edemas ... Jul 12...

December 1, 2019

V.TLT

RE:RE:RE:Is this TLT type liftoff after FDA IND approval?

Oncology drugs, just like in any other industries, have their stock price set...

November 29, 2019

V.TLT

RE:RE:RE:It would be a good idea to load today

Claridge - (11/29/2019 2:46:10 PM) RE:RE:It would be a good idea to load...

November 29, 2019

V.TLT

RE:RE:It would be a good idea to load today

Looks like Bungee forgot to include many things in what it took to bring a...

November 29, 2019

V.TLT

RE:RE:It would be a good idea to load today

Is this Skier59 trying to reach the finish line? lolll ___________________ ...

November 29, 2019

V.TLT

RE:RE:Is this TLT type liftoff after FDA IND approval?

Winr88 ... It even touched 6.57$US at the opening this morning.  Now...

November 29, 2019

V.TLT

RE:Theralase Cannabinoid/PDC/Radiation Patent

Eoganacht ... Great digging.  Thanks for the update.  Cannabioid is...

November 28, 2019

V.TLT

RE:Bladder Cancer Canada approves

z_investor ... Great catch.   I demonstrated many times that TLT was...

November 28, 2019

V.TLT

AUA Advanced Practice Provider of the Year Award

Could Dr. Jewett qualify for this award?   That would di facto give...

November 28, 2019

V.TLT

Collecting data @30 and 60 days ... ;-)

One important difference between Ph. 1b and Ph. 2b ... They seem to have...

November 28, 2019